1. Home
  2. MLGO vs LITS Comparison

MLGO vs LITS Comparison

Compare MLGO & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

HOLD

Current Price

$3.32

Market Cap

38.4M

Sector

Technology

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.16

Market Cap

40.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLGO
LITS
Founded
2018
2000
Country
China
United States
Employees
N/A
4
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.4M
40.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MLGO
LITS
Price
$3.32
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.7K
285.6K
Earning Date
03-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,132,230.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.91
N/A
Revenue Growth
6.21
N/A
52 Week Low
$0.50
$0.95
52 Week High
$32.40
$3.03

Technical Indicators

Market Signals
Indicator
MLGO
LITS
Relative Strength Index (RSI) 38.11 47.25
Support Level $3.30 $1.01
Resistance Level $4.53 $1.16
Average True Range (ATR) 0.30 0.06
MACD -0.01 0.00
Stochastic Oscillator 5.49 11.54

Price Performance

Historical Comparison
MLGO
LITS

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: